NUCLEOBIO
Live / Registered — Registered — Section 8 accepted (as of 22 Apr 2025)
What this means for you
Registered since 14 Aug 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87493575
- Registration number
- 5542268
- Mark type
- Stylized text
- Filed
- 16 Jun 2017
- Published for opposition
- 16 Jan 2018
- Registered
- 14 Aug 2018
- Attorney of record
- Alfred Casillas
Goods and services
- Class 042 — Scientific and technological services: Medical research; Medical research services in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Pharmaceutical drug development services
Owner
- NucleoBio, Inc., San Antonio, TX, US
- NucleoBio, Inc., San Antonio, TX, US
- NucleoBio, Inc., San Antonio, TX, US
Prosecution history
- 22 Apr 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 22 Apr 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 22 Apr 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 Oct 2024 — TEAS SECTION 8 RECEIVED
- 14 Aug 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 14 Aug 2018 — REGISTERED-PRINCIPAL REGISTER
- 07 Jul 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Jul 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Jun 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 09 May 2018 — USE AMENDMENT FILED
- 31 May 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 09 May 2018 — TEAS STATEMENT OF USE RECEIVED
- 13 Mar 2018 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Jan 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Jan 2018 — PUBLISHED FOR OPPOSITION